Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022757
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-08-17
Brief Title:
Study of XNW5004 Tablet in Combination With KEYTRUDA Pembrolizumab in Subjects With Advanced Solid Tumors Who Failed Standard Treatments KEYNOTE F19
Sponsor:
Evopoint Biosciences Inc
Organization:
Evopoint Biosciences Inc
Organization Data
Organization:
Evopoint Biosciences Inc
Class:
INDUSTRY
Study ID:
XNW5004-IbII-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Evopoint Biosciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |